Article
A study of first-degree relatives (FDRs) of HLA-B27-positive axial spondyloarthritis (axSpA) patients shows clinical or imaging features of spondyloarthritis in up to 32% subjects, regardless of HLA-B27 status.
All News
Article
MMWR review of the risk of myocarditis and pericarditis reports a June 23, 2021 recommendation by the Advisory Committee on Immunization Practices that the benefits of COVID-19 vaccination clearly outweighed the risks of myocarditis after vaccination.
Dr. John Cush
Tweet
Doximity Telemedicine report estimates 20% of US medical visits via telehealth; ~$29 billion of medical services in 2020. Top 10 telemedicine specialites:
1 Endocrinology
2 Rheumatology
3 GI
4 Renal
5 Cardiology
6 GU
7 Neuro
8 Geriatrics
9 Hem/Onc
10 Pulm
https://t.co/a8WBEHmNzs
Dr. John Cush
Tweet
6/24/21 FDA has granted emergency use authorization (EUA) for Actemra (tocilizumab) us in treating hospitalized COVID-19 (adults and kids) patients on steroids and who require, supplemental oxygen, mechanical ventilation, or ECMO https://t.co/YAVfbykcti
Dr. John Cush
Tweet
Modest IL-6 mAb benefit w/ COVID. Metanalysis 27 RCTs & 10 930 hosp COVID pts shows 28D all-cause mortality lower w/ IL-6i (vs usual care.PBO) (OR 0.86), better w/ steroids (OR 0.78). Mortality 22% w/ IL-6i vs 25% usual care. https://t.co/rTLjGMMe2g https://t.co/nz1sbKlk2E
Dr. John Cush
Tweet
How should anti-IL-6 mAb therapy be used in COVID-19 infection?
1. w/ corticosteroids
2. Early/severe pts:
3. Hospitalized on O2, but not ventilated
https://t.co/S6DT0Fsjow https://t.co/oeM8EgZk8n
Dr. John Cush
Tweet
Lit review shows there are few good studies patients on the management of hospitalised gout pts. No studies have tested strategies designed to prevent gout re-admissions/flares. Better prospective studies of ULT use by hosp gout is needed https://t.co/OVkMTepa5y
Dr. John Cush
Tweet
HCQ prolongs SLE survival. Case–control study 6241 incident SLE pts compared 290 SLE dead to 502 alive controls. HCQ reduced all-cause mortality by 50% (aOR 0.50; .30–0.82) but HCQ stoppers had incr mortality (aOR 2.47) - sick stopper effect? https://t.co/JIeTJaDVPk
Dr. John Cush
Tweet
185 Lupus pts undergoing renal transplant for ESKD saw good outcomes. Pt survival = 88%, 82%, 78% & 67% (@ 1,3,5,10 yrs). Graft survival was 93%, 89%, 87% & 89% (@ 1,3,5,10 yrs). Immunosuppressive use was protective & only 2 cases of recurrent LN seen https://t.co/xgFYskeX0a
Dr. John Cush
Tweet
Metanalysis of 33 clinical trials show that corticosteroids are anaglesic, especially in 1st 3 mos (mean drop VAS pain -12mm); after that benefit wanes to -8mm @3-6 mos and -6mm (95% CI, -10mm, -2mm) after 6 mos. https://t.co/IKZhqqwhPO
Dr. John Cush
Tweet
Top June Tweet: Pain Persists in RA, Even Without Inflammation
One-third of patients with rheumatoid arthritis had unacceptably high levels of pain 5 years after diagnosis, often despite low levels of inflammation, Swedish researchers found.
https://t.co/K8zf1pE9jM https://t.co/XwdCXnktQN
Dr. John Cush
Tweet
ICYMI: RheumNow Podcast – Tofacitinib Safety Concerns
https://t.co/3Q5OvHRht5 https://t.co/JLFuj5tETw
Dr. John Cush
Tweet
Are you subscribed to RheumNow? Benefits include delivery of new articles right to your inbox, access to downloads and more.
Register today.
https://t.co/riyAnrRHhX
Dr. John Cush
Tweet
Tofacitinib shown to work very well in ankylosing spondylitis.
@RWCSmtg @JointMD https://t.co/bx5FS9BSDZ
Dr. John Cush
Tweet
Throwback Tweet: Hello 2021 and new drug price hikes - on average a 4.2% hike in over 500 drugs (past years saw an avg hike ~5%). Increases include Cosentyx 7%, Humira & Rinvoq 7.4%, Orencia 4.5%, Taltz 5%, Actemra 3%, Benlysta 5%, Xeljanz 4.9% & Cimzia 4%
Dr. John Cush
Tweet
Great Gout Teaching points. Here's my 2 cards on how to Stop #gouta https://t.co/R3EhYFusKf
Dr. John Cush
Tweet
Septic arthritis MIMICs (all presenting as acute monoarthritis) - consider: cellulitis, bursitis, abscess, osteonecrosis, gout, pseudogout, Lyme, Osteomyelitis, reactive arthritis, Lyme disease,, Rheumatoid arthritis, & Transient synovitis (kids) https://t.co/uNirAcoBds
Dr. John Cush
Tweet
Comparison of MSU crystal ID, DECT scanning and US to Dx gout - study of 147 pts. Compared to the gold standard (MSU ID), Feet/ankles (87% sensitivity; 100% specificity) or knees DECT (91%; 87%) alone had best Dx accuracy. US was inferior to DECT. https://t.co/2Hiu7YhLo8
Dr. John Cush
Tweet
Hands-Down Rheumatology - Sarcoidosis usually presents as a monarthritis or oligoarthritis. Late sarcoid arthritis affects knees, ankles, fingers (dactylitis). Bony lesions show honeycomb trabecular pattern).
https://t.co/lmXBbJz6ts https://t.co/oDYrBiPuIX
Dr. John Cush
Tweet
Pirfenidone, studied in 127 pts w/ CVD/CTD ILD, fibrotic interstitial pneumonia, chr hypersensitivity pneumonitis, & asbestoslung fibrosis. Pirefenidone had significantly less FVC% decline compared with placebo (p=0·043)
https://t.co/H1s6ut4NhG
